OVERVIEW
The global market for cellular health screening is expected to hit USD 5.24 billion by 2025, growing over the forecast period at a CAGR of 9.23%. Factors such as the the adoption of telomere efficiency services to lead a healthier life; growing importance of healthy life expectancy (HALE); rising policy emphasis on preventive health care; the geriatric population and the consequent increase in the need for cellular health screening; growing research activities; rising direct-to-consumer approach; and increasing cellular health screening;
TABLE OF CONTENT
1 Global Cellular Health Screening/ Health Testing Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Cellular Health Screening/ Health Testing Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Cellular Health Screening/ Health Testing Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Cellular Health Screening/ Health Testing Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Cellular Health Screening/ Health Testing Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Cellular Health Screening/ Health Testing Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Cellular Health Screening/ Health Testing Market – By Type (Market Size – &
million/billion)
8.1 Single-test Panels
8.2 Multi-test Panels
9 Global Cellular Health Screening/ Health Testing Market – By Sample Collection Site
9.1 At-home
9.2 In office
9.3 Other
10 Global Cellular Health Screening/ Health Testing Market – By Sample Type
10.1 Blood
10.2 Others
11 Global Cellular Health Screening/ Health Testing Market – By Geography (Market Size – &
million/billion)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 U.K
11.3.2 Germany
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Rest of APAC
11.5 Rest of the World
11.5.1 South America
11.5.2 Middle East
11.5.3 Africa
12 Global Cellular Health Screening/ Health Testing Market – Entropy
12.1 New product launches
12.2 M&A’s, collaborations, JVs and partnerships
13 Global Cellular Health Screening/ Health Testing Market Company Profile (Key Players)
13.1 Market Share, Company Revenue, Products, M&A, Developments
13.2 Telomere Diagnostics, Inc. (TDX)
13.3 Spectracell Laboratories
13.4 Life Length
13.5 Labcorp Holdings
13.6 Biorefrence Laboratories
13.7 Cleveland Heartlab, Inc.
13.8 Repeat Diagnostics Inc. (Repeat DX)
13.9 Titanovo
13.10 Cell Science Systems
13.11 Quest Diagnostics
13.12 Company 11 & more
14 Global Cellular Health Screening/ Health Testing Market – Appendix
14.1 Sources
14.2 Abbreviations
